Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults

Marlise Luskin, MDMS, Mark A. Murakami, MDMA,MMSc, Kristen E. Stevenson, MS, Martha Wadleigh, MD, Malgorzata McMasters, MD, Peter Winter, PhD, David M. Weinstock, MD, Richard Stone, MD, Daniel J. DeAngelo, MD PhD

Blood (2019) 134 (Supplement_1): 3879.

https://doi.org/10.1182/blood-2019-125138

Published: 2019

Journal Articles

Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Dimitrios Papaioannou, MD, Deedra Nicolet, MS, Kellie J Archer, PhD, Allison Walker, Krzysztof Mrózek, MD PhD, Andrew J. Carroll, PhD, Jessica Kohlschmidt, PhD, Ann-Kathrin Eisfeld, MD, Marius Bill, MD PhD, Christopher J. Walker, PhD, Geoffrey L. Uy, MD, Bayard L Powell, MD, Jonathan E. Kolitz, MD, Richard Stone, MD, John C. Byrd, MD, Ramiro Garzon, MD, Clara D. Bloomfield, MD

Blood (2019) 134 (Supplement_1): 2694.

https://doi.org/10.1182/blood-2019-125727

Published: 2019

Journal Articles

Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)

Christopher J. Walker, PhD, Ann-Kathrin Eisfeld, MD, Hatice G Ozer, PhD, Jessica Kohlschmidt, PhD, Deedra Nicolet, Krzysztof Mrózek, MD PhD, Dimitrios Papaioannou, MD, Luke K Genutis, BS, Bayard L Powell, MD, Geoffrey L. Uy, MD, Jonathan E. Kolitz, MD, Andrew J. Carroll, PhD, Richard Stone, MD, Ramiro Garzon, MD, John C. Byrd, MD, Albert de la Chapelle, MD PhD, Clara D. Bloomfield, MD

Blood (2019) 134 (Supplement_1): 1247.

https://doi.org/10.1182/blood-2019-127478

Published: 2019

Journal Articles

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Marlise Luskin, MDMS, Eric Zhou, PhD, Zilu Zhang, MS, Daniel J. DeAngelo, MD PhD, Richard Stone, MD, Martha Wadleigh, MD, Jacqueline S Garcia, MD, Eric S. Winer, MD, Christopher Recklitis, PhD, Kelsey O'Day, Victoria Lapiana, Ryan Osborn, David P. Steensma, MD, Gregory A. Abel, MDMPH

Blood (2019) 134 (Supplement_1): 4786.

https://doi.org/10.1182/blood-2019-125147

Published: 2019

Journal Articles

Measuring Mitochondrial Apoptotic Priming by BH3 Profiling Predicts Induction Outcome for Acute Myeloid Leukemia Patients

Thanh-Trang T Vo, MD, Richard Stone, MD, Daniel J DeAngelo, MD, PhD, Mark G. Frattini, MD, PhD, Anthony G. Letai, MD, PhD

Blood (2011) 118 (21): 239.

https://doi.org/10.1182/blood.V118.21.239.239

Published: 2011

Journal Articles

SAR302503: Interim Safety, Efficacy and Long-Term Impact on JAK2 V617F Allele Burden in a Phase I/II Study in Patients with Myelofibrosis,

Animesh Pardanani, MBBS, PhD, Jason Gotlib, M.D., M.S., Catriona Jamieson, Jorge E. Cortes, Moshe Talpaz, Richard Stone, MD, Guozhi Gao, Jenny (Yanzhen) Zhang, MD, PhD, Frank Neumann, MD, PhD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 3838.

https://doi.org/10.1182/blood.V118.21.3838.3838

Published: 2011

Journal Articles

Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition

Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, MSc, Keisuke Ito, MD, PhD, Li Yin, Hasan Rajabi, PhD, Baldev Vasir, PhD, Turner Kufe, Brett Glotzbecker, MD, Katarina Luptakova, MD, Heidi Mills, BA, Robin Joyce, MD, Dimitrios Tzachanis, MD, PhD, Vassiliki A Boussiotis, MD, PhD, James Levine, MD, Ilene Galinsky, ANP, Richard Stone, MD, Pier Paolo Pandolfi, MD, PhD, Donald Kufe, MD, David Avigan, MD

Blood (2010) 116 (21): 848.

https://doi.org/10.1182/blood.V116.21.848.848

Published: 2010

Journal Articles

Identification of Potential Therapeutic Targets Using Genome-Wide Analysis of Alternative Splicing (AS) In Patients with Acute Myeloid Leukemia (AML)

Sophia Adamia, Hervé Avet-Loiseau, Laurence Lodé, Michal Bar-Natan, Sigitas Verselis, PhD, Edward Fox, Ilene Galinsky, ANP, Philippe Moreau, Richard Stone, MD, James D. Griffin, MD

Blood (2010) 116 (21): 177.

https://doi.org/10.1182/blood.V116.21.177.177

Published: 2010

Journal Articles

Identification of Novel Splice Variants of Multiple Genes Using Genome-Wide Analysis of Alternative Splicing in Patients with Acute Myeloid Leukemia.

Sophia Adamia, Michal Bar-Natan, M.D, Richard Stone, MD, James D Griffin

Blood (2009) 114 (22): 1278.

https://doi.org/10.1182/blood.V114.22.1278.1278

Published: 2009

Journal Articles

A Phase I Evaluation of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis: Clinical Response Is Accompanied by Significant Reduction in JAK2 V617F Allele Burden.

Animesh D. Pardanani, MBBS, PhD, Jason R Gotlib, MD, MS, Catriona Jamieson, MD, PhD, Jorge Cortes, MD, Moshe Talpaz, MD, Richard Stone, MD, Michael H Silverman, MD, FACP, Jolene Shorr, D. Gary Gilliland, MD, PhD, Ayalew Tefferi, MD

Blood (2009) 114 (22): 755.

https://doi.org/10.1182/blood.V114.22.755.755

Published: 2009

Journal Articles

Perceptions of Disease State, Treatment Expectations, and Prognosis Among Patients with Myelodysplastic Syndromes.

Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, Alan F List, MD, David P Steensma, Andrew Artz, MD, MS, Arlene S. Swern, Paul Scribner, John Huber, Richard Stone, MD

Blood (2009) 114 (22): 1771.

https://doi.org/10.1182/blood.V114.22.1771.1771

Published: 2009

Journal Articles

Adoptive T Cell Therapy Using Educated T Cells Generated by the Sequential Stimulation with DC/Tumor Fusion Cells and Anti-CD3CD28

Jacalyn Rosenblatt, MD, Baldev Vasir, PhD, Zekui Wu, MD, Corrine Zarwan, MD, Richard Stone, MD, Adam Bissonnette, Thea M Friedman, PhD, Donna Neuberg, ScD, Natalya Rozenveyn, Brett Glotzbecker, MD, James D. Levine, MD, MS, Robin Joyce, MD, Vassiliki Boussiotis, MD, Dimitrios Tzachanis, MD, Dimitrios Spentzos, MD, Panagiotis Konstantinopoulos, MD, Donald Kufe, MD, David Avigan, MD

Blood (2008) 112 (11): 2913.

https://doi.org/10.1182/blood.V112.11.2913.2913

Published: 2008

Journal Articles

The Role of RNA Helicase Dead Box 18 in Zebrafish Hematopoiesis and Human MDS

Elspeth Payne, MB, ChB, Niccolo Bolli, MD, Clemens Grabher, Jennifer Rhodes, PhD, John Kanki, Ilene Galinsky, ANP, Richard Stone, MD, Finbar E Cotter, FRCP, FRCPath, PhD, A. Thomas Look, MD

Blood (2008) 112 (11): 500.

https://doi.org/10.1182/blood.V112.11.500.500

Published: 2008

Journal Articles

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Jacalyn Rosenblatt, MD, Zekui Wu, MD, Corrine Lenahan, MD, Adam Bissonnette, Baldev Vasir, PhD, Kenneth Miller, MD, Robin Joyce, MD, James Levine, MD, Ilene Galinsky, RN, Richard Stone, MD, Donald Kufe, MD, David Avigan, MD

Blood (2007) 110 (11): 1794.

https://doi.org/10.1182/blood.V110.11.1794.1794

Published: 2007

Journal Articles

An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia.

Benjamin L. Ebert, MD, PhD, Naomi Galili, PhD, Pablo Tamayo, PhD, Raymond Mak, Jennifer Pretz, Christine Ladd-Acosta, Richard Stone, MD, Todd R. Golub, MD, Azra Raza, MD

Blood (2006) 108 (11): 2668.

https://doi.org/10.1182/blood.V108.11.2668.2668

Published: 2006

Journal Articles

Monitoring Imatinib Resistance with a “Polony” Assay: Towards Tailored Therapy of Chronic Myelogenous Leukemia (CML).

Valentina Nardi, MD, Tal Raz, PhD, Xinyu Chao, Catherine J. Wu, MD, Richard Stone, MD, Ilene Galinsky, RN, NP, Martha Wadleigh, MD, Michael W.N. Deininger, MD, PhD, George Church, PhD, Jun Zhu, PhD, George Q. Daley, MD, PhD

Blood (2006) 108 (11): 837.

https://doi.org/10.1182/blood.V108.11.837.837

Published: 2006

Journal Articles

Leukemia Derived Dendritic Cells (LDCs) Are Functionally Deficient and Inferior to DC/Leukemia Fusion Cells as a Tumor Vaccine for AML.

Jacalyn Rosenblatt, MD, Richard Stone, MD, Corrine Lenahan, MD, Zekwui Wu, MD, Baldev Vasir, PhD, Daniel J. DeAngelo, MD, Ilene Galinsky, RN, Kenneth Miller, MD, James D. Levine, MD, Robin Joyce, MD, Donald Kufe, MD, David Avigan, MD

Blood (2005) 106 (11): 2788.

https://doi.org/10.1182/blood.V106.11.2788.2788

Published: 2005

Journal Articles

Pharmacokinetic and Pharmacodynamic Studies of Lestaurtinib (CEP-701) and PKC-412: Cytotoxicity Is Often Dependent on Non-FLT3-Mediated Effects.

Mark Levis, MD, PhD, Adam Stine, BS, Rosalyn, Pham BS, B. Douglas Smith, MD, Judith Karp, MD, Richard Stone, MD, Elihu Estey, MD, Frank Giles, MD, Hagop Kantarjian, MD, Pamela Cohen, MD, Yanfeng Wang, PhD, Donald Small, MD, PhD

Blood (2005) 106 (11): 2463.

https://doi.org/10.1182/blood.V106.11.2463.2463

Published: 2005

Journal Articles

Similar Outcome of Non-Myeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients Greater Than Fifty Years of Age.

Edwin P. Alyea, MD, Haesook Kim, PhD, Corey Cutler, MD, Vincent T. Ho, MD, John Gribben, MD, PhD, Daniel J. DeAngelo, MD, Stephanie J. Lee, MD, Sarah Windawi, Richard Stone, MD, Jerome Ritz, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2004) 104 (11): 300.

https://doi.org/10.1182/blood.V104.11.300.300

Published: 2004

NARROW

A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults

Next-Generation RNA Sequencing-Based Analysis Identifies a Novel Set of Prognostic Micrornas (miRs) in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Measuring Mitochondrial Apoptotic Priming by BH3 Profiling Predicts Induction Outcome for Acute Myeloid Leukemia Patients

SAR302503: Interim Safety, Efficacy and Long-Term Impact on JAK2 V617F Allele Burden in a Phase I/II Study in Patients with Myelofibrosis,

Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition

Identification of Potential Therapeutic Targets Using Genome-Wide Analysis of Alternative Splicing (AS) In Patients with Acute Myeloid Leukemia (AML)

Identification of Novel Splice Variants of Multiple Genes Using Genome-Wide Analysis of Alternative Splicing in Patients with Acute Myeloid Leukemia.

A Phase I Evaluation of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis: Clinical Response Is Accompanied by Significant Reduction in JAK2 V617F Allele Burden.

Perceptions of Disease State, Treatment Expectations, and Prognosis Among Patients with Myelodysplastic Syndromes.

Adoptive T Cell Therapy Using Educated T Cells Generated by the Sequential Stimulation with DC/Tumor Fusion Cells and Anti-CD3CD28

The Role of RNA Helicase Dead Box 18 in Zebrafish Hematopoiesis and Human MDS

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia.

Monitoring Imatinib Resistance with a “Polony” Assay: Towards Tailored Therapy of Chronic Myelogenous Leukemia (CML).

Leukemia Derived Dendritic Cells (LDCs) Are Functionally Deficient and Inferior to DC/Leukemia Fusion Cells as a Tumor Vaccine for AML.

Pharmacokinetic and Pharmacodynamic Studies of Lestaurtinib (CEP-701) and PKC-412: Cytotoxicity Is Often Dependent on Non-FLT3-Mediated Effects.

Similar Outcome of Non-Myeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients Greater Than Fifty Years of Age.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only